Position in NAGE
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$5,931,100
-$2,304,228 QoQ
Shares Held
1,344,921
+3.9% QoQ
Ownership
1.69%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NAGE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GEODE CAPITAL MANAGEMENT, LLC holds $18,583,356,554 across 528 Biotechnology names. NAGE ranks #198 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,139,621 | $2,741,586,360 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,607,732 | $2,014,838,051 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,660,385 | $880,241,584 | |
| 4 | INSM |
INSMED Inc
|
4,450,389 | $727,727,608 | |
| 5 | MRNA |
Moderna, Inc.
|
9,435,132 | $479,304,705 | |
| 6 | INCY |
Incyte Corp
|
4,703,184 | $442,663,677 | |
| 7 | RPRX |
Royalty Pharma plc
|
7,869,632 | $377,506,246 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
4,918,030 | $365,212,906 |
All Filings in NAGE
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,931,100 | 1,344,921 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $8,235,328 | 1,294,863 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $12,086,706 | 1,295,467 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $18,667,938 | 1,295,485 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $8,136,596 | 1,179,217 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $6,131,870 | 1,154,778 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $4,196,010 | 1,149,592 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $3,089,346 | 1,131,629 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $1,952,485 | 561,059 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $720,638 | 503,943 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $735,756 | 503,943 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $823,306 | 524,399 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $852,875 | 557,435 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $938,866 | 558,849 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $680,589 | 553,325 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $916,390 | 548,737 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $2,273,194 | 924,063 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $3,295,942 | 881,268 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $5,418,621 | 864,214 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $8,092,417 | 820,732 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $6,871,783 | 735,737 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $3,150,840 | 656,425 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $2,525,642 | 629,836 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $2,813,587 | 612,982 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $1,915,680 | 587,632 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||